Epigral Limited Schedules Investor-Analyst Meet for April 13, 2026
Epigral Limited has scheduled an investor and analyst meeting for April 13, 2026, organized by Sunidhi Securities & Finance Ltd. via video conferencing. The company has notified stock exchanges under SEBI Regulation 30, ensuring regulatory compliance. No unpublished price sensitive information will be shared during the meeting, and relevant presentations are available on the company's website.

*this image is generated using AI for illustrative purposes only.
Epigral Limited has announced an upcoming investor and analyst meeting, demonstrating its commitment to maintaining transparent communication with stakeholders. The company has formally notified stock exchanges about this scheduled interaction under regulatory compliance requirements.
Meeting Details and Schedule
The investor meeting has been organized by Sunidhi Securities & Finance Ltd. and will be conducted through video conferencing technology. The company has provided specific details about the upcoming interaction:
| Parameter: | Details |
|---|---|
| Meeting Type: | Investors/Analysts meet organized by Sunidhi Securities & Finance Ltd. |
| Date: | April 13, 2026 |
| Mode: | Video Conferencing (V.C.) |
| Location: | Not Applicable |
Regulatory Compliance and Transparency
Epigral Limited has fulfilled its regulatory obligations by informing both the National Stock Exchange of India Limited and BSE Limited about this meeting. The notification was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring proper disclosure to market participants.
The company has emphasized its commitment to maintaining information transparency by stating that no unpublished price sensitive information will be shared or discussed during the meeting with investors. This approach aligns with regulatory requirements and ensures fair disclosure practices.
Available Resources and Documentation
Epigral has made relevant presentation materials accessible to participants ahead of the meeting. The latest Earnings Presentation and Corporate Presentation that may be discussed during the session have already been placed on the company's official website at www.epigral.com . This proactive approach allows participants to review materials in advance and prepare for meaningful discussions.
Schedule Flexibility
The company has noted that the meeting schedule remains subject to change due to potential exigencies on the part of institutional investors or the company itself. This flexibility acknowledges the dynamic nature of corporate scheduling and ensures accommodation for unforeseen circumstances that may affect participation.
The formal notification was signed by Gaurang Trivedi, Company Secretary and Compliance Officer, on April 9, 2026, demonstrating proper corporate governance procedures in the communication process.
What key strategic initiatives or business developments is Epigral likely to discuss that could impact its stock performance post-meeting?
How might the outcomes of this investor meeting influence Epigral's future fundraising capabilities and institutional investor interest?
Will Epigral's engagement with Sunidhi Securities signal potential expansion of its investment banking relationships or advisory services?

































